Molecular diagnostics companies develop and supply technologies that detect disease-associated DNA, RNA and other defined molecular signatures in human clinical samples. Their products support infectious disease testing, genetic diagnosis, cancer profiling and precision medicine, from central laboratory workflows to rapid near-patient assays.
This category includes companies working on:
Browse 51 UK molecular diagnostics companies below.
Rapid genomic diagnostic device for sepsis and bacterial infections
GenomeKey is a biotechnology company developing an in vitro diagnostic device that uses whole genome sequencing and machine learning to identify bacteria and their antimicrobial resistance profiles directly from patient blood within hours. The device targets sepsis, where current culture-based diagnostics take 24 to…
Instruments, reagents, and diagnostics for life science research and clinical laboratories
Bio-Rad Laboratories Limited is the UK subsidiary of Bio-Rad Laboratories, Inc., a global manufacturer of instruments and reagents for life science research and clinical diagnostics. Its life science portfolio spans electrophoresis, PCR and digital droplet PCR, flow cytometry, protein purification, multiplex…
National genomics research and NHS whole genome sequencing
Genomics England is a government-owned organisation that partners with the NHS to deliver whole genome sequencing diagnostics and advance genomic medicine in the UK. It operates the National Genomic Research Library, providing approved researchers with access to linked genomic and clinical data to identify the causes…
Point-of-care molecular diagnostic platform for rapid infectious disease detection
Diagnostics for the Real World (Europe) is a Cambridge University spin-out developing and commercialising a fully automated point-of-care molecular diagnostic system for rapid detection of infectious diseases. Using isothermal nucleic acid amplification, the platform delivers sample-in-result-out testing without…
Rapid point-of-care molecular diagnostics for infectious disease
Llusern Scientific is a diagnostics company developing portable, rapid molecular diagnostic systems for use at the point of care. Using isothermal amplification technology, the company's platform identifies bacterial pathogens directly from patient samples without laboratory infrastructure, delivering results within…
Point-of-care pharmacogenetic testing platform for emergency healthcare
Genedrive is a molecular diagnostics company developing point-of-need pharmacogenetic tests that identify genetic variants to guide safer, more personalised medicine decisions in time-critical emergency care. Its flagship products, developed and validated with NHS partners, include a neonatal test preventing…
Multiplex PCR and NGS diagnostics for cancer and infection
GeneFirst is a molecular diagnostics company developing multiplex PCR assays and next-generation sequencing technologies for cancer screening, precision oncology and infectious disease testing. Its Papilloplex assays detect high-risk human papillomavirus DNA or E6/E7 mRNA. The XCeloSeq platform provides library…
Lateral flow rapid test development, manufacturing and regulatory services
Abingdon Health is a contract development and manufacturing organisation specialising in lateral flow rapid diagnostic tests. It provides end-to-end services spanning assay development, scale-up manufacturing, regulatory approval and commercialisation support across healthcare, animal health and plant health. The…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free soluble nanoarray technology enables simultaneous quantification of up to 200 RNA and DNA targets from low-input samples within one hour.…
Predictive genetic tests for cancer and cardiovascular disease
GENinCode is a clinical-stage diagnostics company developing polygenic risk assessment tests for cardiovascular disease and ovarian cancer. Its portfolio includes CE-marked molecular tests for coronary artery disease, familial hypercholesterolaemia and thrombosis risk, alongside the ROCA test for ovarian cancer…
Rapid point-of-care molecular testing for sexually transmitted infections
Binx Health is a diagnostics company that develops and manufactures a rapid point-of-care molecular testing platform for sexually transmitted infections. Its benchtop instrument and single-use cartridges detect the genetic material of chlamydia and gonorrhoea from patient samples in around 30 minutes, allowing…